Zacks Investment Research on MSN
Tandem Diabetes Care (TNDM) reports Q3 earnings: What key metrics have to say
Tandem Diabetes Care, Inc. (TNDM) reported $283.69 million in revenue for the quarter ended September 2026, representing a year-over-year increase of 13.8%. EPS of -$0.10 for the same period compares ...
Among veterans with type 2 diabetes who did not tolerate an initial GLP-1 medication, half tolerated an ...
Jeannette Bankes named President and CEO of Tandem Diabetes Care in planned transition as John Sheridan Retires After Over a ...
"A diabetes diagnosis is not a personal failing," writes Nick Jonas. "There should be no shame in understanding your risk and ...
Small changes are important, Cohen said about the trial, whose mission was to measure blood pressure reduction, not ...
Zacks Investment Research on MSN
Tandem Diabetes Care, Inc. (TNDM) reports Q3 loss, beats revenue estimates
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.31 per share a year ago. These ...
A new systematic review protocol aims to evaluate the performance of Leicester risk scores for detecting undiagnosed type 2 diabetes across diverse populations.
Many patients never connect diabetes with changes in sexual health, leaving clinicians to recognize concerns that may otherwise go unspoken during routine care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results